This paper explains the controversy about including all of a large reconstruction flap in the RT target volume versus only the perimeter of the flap. Available guidelines regarding the issue are reviewed as are outcome studies that inform the subject.

This session will include an introduction covering common head and neck cancer subtypes. Basics of head and neck anatomy will be reviewed. Subsequently, we will transition to a case-based approach that will demonstrate target volume design for common head and neck tumor types.

There are many ongoing advances in head and neck cancer in the context of radiation therapy delivery, clinical research on treatment options and advanced techniques in radiotherapy delivery. Failure to stay informed leads to lower quality of care by practicing clinicians.

This session highlights the most clinically relevant abstracts within the Head and Neck Cancer track of the 2023 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.

There are many ongoing clinical trials in head and neck squamous cell carcinoma (HNSCC) that offer potential therapeutic benefits to HNSCC patients. This session summarizes those trials and their results.

There are many ongoing clinical trials in head and neck squamous cell carcinoma (HNSCC) that offer potential therapeutic benefits to HNSCC patients. This session summarizes those trials and their results.

Patients diagnosed with head and neck cancers undergo treatments which include various combinations of surgery, radiation and chemotherapy. These treatments result in short and long-terms side effects and complications that could be life altering for these patients.

Skull-based cancers are complex and heterogeneous diseases that require complex multidisciplinary management between head and neck surgeons, medical oncologists and radiation oncologists. Emerging data has given novel insights into the optimal treatment of sinonasal and skull-based malignancies.

Skull-based cancers are complex and heterogeneous diseases that require complex multidisciplinary management between head and neck surgeons, medical oncologists and radiation oncologists. Emerging data has given novel insights into the optimal treatment of sinonasal and skull-based malignancies.